Market research
EYEGW Eyegate Pharmaceuticals Inc. Wt Exp 2020
NASDAQ USD Other
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- Not available
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the EYEGW discussion.
5 years, 4 months ago
Eyegate Pharmaceuticals Inc. Wt Exp 2020 is currently in a long term downtrend where the price is trading 27.0% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Other sector with a price to sales ratio of 0.0.
Based on the above factors, Eyegate Pharmaceuticals Inc. Wt Exp 2020 gets an overall score of 1/5.